Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: Results of post-marketing surveillance

Vaccine

Volumn 21, Issue 7-8, 2003, Pages 742-745

  Pavlova, Borislava G ^a   Loew Baselli, Alexandra ^a   Fritsch, Sandor ^a   Poellabauer, Eva Maria ^a   Vartian, Nina ^a   Rinke, Ingeborg ^a   Ehrlich, Hartmut J ^a  

^a BAXTER BIOSCIENCE   (Austria)

Author keywords

Fever rate; FSME IMMUN "NEW"; Post marketing surveillance; Tick borne encephalitis (TBE)

Indexed keywords

TICK BORNE ENCEPHALITIS VACCINE;

BODY TEMPERATURE; CONFERENCE PAPER; CONVULSION; DATA ANALYSIS; DOSE RESPONSE; EMBRYO CELL; FEVER; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; MEDICAL PRACTICE; MORTALITY; POPULATION; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; TICK BORNE ENCEPHALITIS; VACCINATION;

ANTIGENS, VIRAL; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS, TICK-BORNE; FEVER; HUMANS; INFANT; PRODUCT SURVEILLANCE, POSTMARKETING; VACCINATION; VIRAL VACCINES;

EID: 0037472393     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00593-5     Document Type: Article

References (11)

1. Monath TP, Heinz FX. Flavivirus. In: Fields BN, editor. Fields virology. Philadelphia: Lippincott-Raven Publishers; 1996. p. 961-1034.
2. Doser A.K., Hartmann K., Fleisch F., Kuhn M. Suspected neurological side-effects of tick-borne meningoencephalitis vaccination: Experiences of the Swiss Adverse Drug Reaction Reporting Center. Schweiz Rundsch Med. Prax. 91(5):2002;159-162.
3. Kunze U., Bernhard G., Bohm G., Groman E. Early-summer meningo-encephalitis (ESME) and ESME-vaccination: Status 2000. Wien. Med. Wochenschr. 150(5):2000;103-108.
4. Kaiser R., Holzmann H. Laboratory findings in tick-borne encephalitis - correlation with clinical outcome. Infection. 28(2):2000;78-84.
5. Cizman M., Rakar R., Zakotnik B., Pokorn M., Arnez M. Severe forms of tick-borne encephalitis in children. Wien. Klin. Wochenschr. 111(12):1999;484-487.
6. Girgsdies O.E., Rosenkranz G. Tick-borne encephalitis: Development of a paediatric vaccine: a controlled, randomized, double-blind and multicentre study. Vaccine. 14(15):1996;1421-1428.
7. Niu MT, Salive ME, Ellenberg SS. Post-marketing surveillance for adverse events after vaccination: The national Vaccine Adverse Event Reporting System (VAERS). Food and Drug Administration Medwatch Continuing Education Article, 1998.
8. Valle P.C., Kildahl-Andersen O., Steinvoll K. A comparative study of infrared tympanic thermometry and rectal mercury thermometry. Scand. J. Infect. Dis. 31(1):1999;105-106.
9. Meates M. Ambulatory paediatrics - making a difference. Arch. Dis. Child. 76(5):1997;468-473.
10. Tatman M.A., Woodroffe C., Kelly P.J., Harris R.J. Paediatric home care in Tower Hamlets: A working partnership with parents. Qual. Health Care. 1(2):1992;98-103.
11. Market research report in Austria, by FESSEL-GfK. Institute for Market Research, 2000.